{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Ocean Biomedical, Inc.
Is Ocean Biomedical, Inc. technically bullish or bearish?
As of May 1, 2025, the trend is mildly bearish due to daily moving averages indicating bearish momentum, despite some mildly bullish signals from the weekly MACD and KST, resulting in a lack of strong bullish momentum overall.
What does Ocean Biomedical, Inc. do?
Ocean Biomedical, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $8 million and a market cap of $1.71 million. Key metrics include a negative P/E ratio, a 0.00% dividend yield, and a return on equity of 32.08%.
How big is Ocean Biomedical, Inc.?
As of Jun 18, Ocean Biomedical, Inc. has a market capitalization of 1.71 million, with net sales of 0.00 million and a net profit of -30.72 million over the latest four quarters. Shareholder's funds are reported at -97.62 million, and total assets amount to 0.90 million.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
